Alzamend Neuro, Inc. (ALZN): Nasdaq/NYSE listing notice — Alzamend Neuro granted Nasdaq extension to Nov 15, 2023; must execute reverse stock split by Nov 1

Alzamend Neuro, Inc.

Nasdaq Hearings Panel grants extension until Nov 15, 2023 to regain $1.00 minimum bid compliance.
Conditions: obtain stockholder approval for reverse stock split (ratio 1:2 to 1:20) by Sept 29, 2023.
Company must effect reverse stock split by Nov 1, 2023 and then maintain $1.00 closing bid for 10 consecutive business days.
Annual stockholder meeting scheduled for Sept 29, 2023 to approve reverse stock split.

item 7.01 item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Alzamend Neuro, Inc. received a nasdaq extension granted notice regarding minimum bid price.

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price

Exact text from the filing

September 22, 2023, the Company issued a press release to announce the extension granted by the Nasdaq Hearings Panel. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. In accordance with General Instruction B.2 of Form 8-K, the information under this item shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific referen

View on SEC.gov

Browse all listing & compliance notices →

Alzamend Neuro, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-23-012579

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.